National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

transdermal estrogen
A transdermal formulation containing the synthetic form of estradiol, the most potent, endogenously produced estrogen. Upon topical administration, estradiol diffuses through the cell membrane and binds to and activates specific intracellular estrogen receptors located on estrogen-responsive tissues, including the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated ligand-receptor complex binds to estrogen response elements on DNA and promotes the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics. In addition, estradiol inhibits the pituitary secretion of the gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH) through a negative feedback mechanism. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:EstroGel



Previous:Totect, tozasertib lactate, TPI 287, trabectedin, tranexamic acid
Next:transferrin receptor-targeted anti-RRM2 siRNA CALAA-01, transferrin receptor-targeted liposomal p53 cDNA, transferrin-CRM107, transgenic lymphocyte immunization vaccine, TransMID

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov